Does intravenous lidocaine associated with spinal anesthesia reduce post-operative pain after C-Section? The i-Lido-CA Trial - Trial PACTR202310783988259
Access comprehensive clinical trial information for PACTR202310783988259 through Pure Global AI's free database. This Phase 4 trial is sponsored by Syrine Aguir and is currently Not yet recruiting. The study focuses on Surgery; Anaesthesia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Syrine Aguir
Timeline & Enrollment
Phase 4
Jan 01, 1900
Jan 01, 1900
Summary
Postoperative pain associated with Cesarean sections has significant socioeconomic implications, including potential risks of chronic pain and postpartum depression. Effective pain management improves recovery and maternal well-being, especially in Enhanced Recovery After Cesarean Surgery (ERACS). Spinal anesthesia is commonly used for cesarean sections, but it can lead to side effects such as nausea and vomiting. The management of postoperative pain involves multimodal analgesia, such as intrathecal opioids and non-opioid analgesics. To address these issues and enhance postoperative recovery, various medications and techniques have been explored, including intravenous lidocaine. We aim in this research study to evaluate the analgesic and hemodynamic benefits of intravenous lidocaine for cesarean section under spinal anesthesia.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202310783988259
Non-Device Trial